AstraZeneca announces new strategic collaboration with insitro to use advanced AI systems to develop transformative therapeutics for difficult to treat cardiometabolic diseases
AstraZeneca today announced that it has entered into a new strategic drug discovery collaboration and licensing agreement with insitro, a ...
































